Meeting abstracts
AAD 2026
American Academy of Dermatology · Denver, 27–31 March 2026
1,877 abstracts, published in JAAD on 6 July 2026. Their text is on the JAAD website.
- 71146
Beyond the Face: Treating Truncal Acne with Sarecycline - a Multinational Phase 3 Pooled Analysis
Del Rosso JQ, Zhang J, … senior author Garcia-Gil E
- 73022
- 73388
Activity of Topical Antifungals Against the Terbinafine-Resistant Dermatophyte Trichophyton indotineae: In Vivo Analysis
Ghannoum M, Saghir J, … senior author McCormick T
- 73781
- 74740
Terbinafine gel (HSG-42) investigated for toenail onychomycosis, including resistant dermatophytoma: a case study from a Phase 2a open-label trial
Vlahovic T, Jones T, … senior author Rich P
- 74807
- 75362
Assessing Virulence Factor Profiles and Macrolide-Clindamycin Resistance Genes in Clinical Isolates of Cutibacterium acnes (C. acnes)
Ghannoum M, Samiksha F, … senior author McCormick TS
- 75448
Acne and Skin Oiliness Improvements With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% (CAB) Gel: Post Hoc Analysis of 12-Week and 24-Week Studies
Draelos ZD, Tanghetti EA, … senior author Kircik LH
- 75490
Advocacy for Antimicrobial Stewardship in Michigan Medicaid: A Dermatology-Pharmacy Collaboration
Libson K, Hoekwater L, … senior author Asch S
- 75516
- 75537
In Vitro Activity of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Fungal Acne
Ghannoum M, Roberts KD, … senior author McCormick TS
- 75746
- 75940
- 76117
Doxy and Derm: Will Doxy-PEP drive the emergence of tetracycline-resistant Staphylococcus aureus skin infections? A review
Huynh T, Macias-Gil R, Miller L
- 76483
Oral doxycycline dosing and treatment pathways in acne: A multi-center cohort study, 2010-2022
Smith C, Murdock A, … senior author Yeung H
- 76569
Two Cases of Hidradenitis Suppurativa Treated with Sarecycline
Boby A, Silverberg N
- 76791
Efficacy of sarecycline in the treatment of moderate-to-severe facial acne vulgaris (AV): Combined results from three phase 3 studies
Del Rosso J, Gold LS, … senior author Tan J
- 76863
Efficacy of Oral DFD-29, a Low-Dose Minocycline Formulation, by Baseline Rosacea Severity in Two Phase 3 Trials
Sidgiddi S, Gold LS, Gallo R, et al.
- 76964
That's every abstract.